Locus coeruleus promotes survival of dopamine neurons in ventral mesencephalon. An in oculo grafting study

Experimental Neurology

Volumn 216, Issue 1, 2009, Pages 158-165

  Berglöf, Elisabet ^a   Strömberg, Ingrid ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Development; Dopamine; Grafting; Locus coeruleus; Noradrenaline; Ventral mesencephalon

Indexed keywords

ALDEHYDE DEHYDROGENASE; CALBINDIN; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPAMINERGIC NERVE CELL; FEMALE; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; LOCUS CERULEUS; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NERVE TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL COMMUNICATION; CELL SURVIVAL; DOPAMINE; EYE; FEMALE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; GROWTH CONES; LOCUS COERULEUS; MESENCEPHALON; NEURONS; NOREPINEPHRINE; OPHTHALMOLOGIC SURGICAL PROCEDURES; RATS; RATS, SPRAGUE-DAWLEY; RETINAL DEHYDROGENASE; TYROSINE 3-MONOOXYGENASE;

EID: 59749106683     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.11.029     Document Type: Article

References (50)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 94 (1946) 239-247
2. Agid Y. Parkinson's disease: pathophysiology. Lancet 337 (1991) 1321-1324
3. Björklund H., Olson L., Seiger Å., and Hoffer B. Chronic lead and brain development: intraocular brain grafts as a method to reveal regional and temporal effects in the central nervous system. Environ. Res. 22 (1980) 224-236
4. Björklund L., Spenger C., and Strömberg I. Tirilazad mesylate increases dopaminergic neuronal survival in the in oculo grafting model. Exp. Neurol. 148 (1997) 324-333
5. Cenci M., Nilsson O., Kalén P., and Björklund A. Characterization of in vivo noradrenaline release from superior cervical ganglia or fetal locus coeruleus transplanted to the subcortically deafferentiated hippocampus in the rat. Exp. Neurol. 122 (1993) 73-87
6. Chan-Palay V. Alterations in the locus coeruleus in dementias of Alzheimer's and Parkinson's disease. Prog. Brain Res. 88 (1991) 625-630
7. Chung S., Hedlund E., Hwang M., Kim D.W., Shin B.-S., Hwang D.-Y., Kang U.J., Isacson O., and Kim K.-S. The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons. Mol. Cell Neurosci. 28 (2005) 241-252
8. Collingridge G., James T., and MacLeod N. Neurochemical and electrophysiological evidence for a projection from the locus coeruleus to the substantia nigra. J. Physiol. 290 (1979) 44
9. Conner J., and Varon S. Nerve growth factor influences the distribution of sympathetic sprouting into the hippocampal formation by implanted superior cervical ganglia. Exp. Neurol. 130 (1994) 15-23
10. Ebendal T., Olson L., and Seiger Å. The level of nerve growth factor (NGF) as a function of innervation. A correlative radioimmunoassay and bioassay study of the rat iris. Exp. Cell Res. 148 (1983) 311-317
11. Ebendal T., Strömberg I., Olson L., and Seger Å. Parasympathetic neurotrophic activity in the rat iris: determination after different denervation. Neurosci. 16 (1985) 181-185
12. Ehringer H., and Hornykiewicz O. Verteilung von noradrenalin und dopamin (3-hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems. Klin. Wschr. 38 (1960) 1236-1239
13. Eriksdotter-Nilsson M., Gerhardt G., Seiger Å., Olson L., Hoffer B., and Granholm A.-C. Age-related alterations in noradrenergic input to the hippocampal formation: structural and functional studies in intraocular transplants. Brain Res. 478 (1988) 269-280
14. Gerfen C.R., Baimbridge K.G., and Miller J.J. The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 8780-8784
15. Gerhardt G.A., Palmer M.R., and Granholm A.-C. Age-induced changes in single locus coeruleus brain transplants grown in oculo: an in vivo electrochemical study. Neurobiol. Aging 12 (1991) 487-494
16. German D., Manaye K., White III C., Woodward D., McIntire D., Smith W., Kalaria R., and Mann D. Disease-specific patterns of locus coeruleus cell loss. Ann. Neurol. 32 (1992) 667-676
17. Gesi M., Soldani P., Giorgi F.S., Santinami A., Bonaccorsi I., and Fornai F. The role of locus coeruleus in the development of Parkinson's disease. Neurosci. Biobehav. Rev. 24 (2000) 655-668
18. Giacobini M.M.J., Strömberg I., Almström S., Cao Y., and Olson L. Fibroblast growth factors enhance dopamine fiber formation from nigral grafts. Dev. Brain Res. 75 (1993) 65-73
19. Granholm A.-C.E., Curtis M., Diamond D.M., Branch B.J., Heman K.L., and Rose G.M. Development of an intact blood-brain barrier in brain tissue transplants is dependent on the site of transplantation. Cell Transplant. 5 (1996) 305-314
20. Haque N.S.K., LeBlanc C.J., and Isacson O. Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons. Cell Transplant. 6 (1997) 239-248
21. 3H]-racloproide binding to dopamine D2 receptors and D2 receptor-G protein interaction in the rat striatum. Brain Res. 976 (2003) 209-216
22. Heneka M., Gavriluyk V., Landreth G., O'Banion M., Weinberg G., and Feinstein D. Noradrenergic depletion increases inflammatory responses in brain: effects on kappaB and HSP70 expression. J. Neurochem. 85 (2003) 387-398
23. Itakura T., Kamei I., Nakai K., Naka Y., Nakakita K., Imai H., and Komai N. Autotransplantation of the superior cervical ganglion into the brain. J. Neurosurg. 68 (1988) 955-959
24. Jones B., and Moore R. Ascending projections of the locus coeruleus in the rat II: autoradiographic study. Brain Res. 127 (1977) 25-53
25. Jones B., and Yang T.-Z. The efferent projections from the reticular formation and the locus coeruleus studied by anteriograde and retrograde axonal transport in the rat. J. Comp. Neurol. 242 (1985) 56-92
26. Katsuki H., Izui Y., and Zorumski C. Noradrenergic regulation of synaptic plasticity in the hippocampal CA1 region. J. Neurophysiol. 77 (1997) 3013-3020
27. Kilbourn M., Sherman P., and Abbott L. Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering. Synapse 30 (1998) 205-210
28. Kish S.J., Shannak K., and Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. New Engl. J. Med. 318 (1988) 876-880
29. Leanza G., Cataudella T., Dimauro R., Monaco S., and Stanzani S. Release properties and functional integration of noradrenergic-rich tissue grafted to the denervated spinal cord of the adult rat. Eur. J. Neurosci. 11 (1999) 1789-1799
30. Mahalik T.J., Hahn W.E., Clayton G.H., and Owens G.P. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129 (1994) 27-36
31. Mann D. The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mech. Ageing Dev. 23 (1983) 73-94
32. Marien M., Briley M., and Colpaert F. Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice. Eur. J. Pharmacol. 236 (1993) 487-489
33. Mavridis M., Degryse A.-D., Lategan A., Marien M., and Colpaert F. Effects of locus coeruleus lesion on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease. Neuroscience 41 (1991) 507-523
34. McCaffery P., and Drager U.C. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 7772-7776
35. McRitchie D., Hardman C., and Halliday G. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J. Comp. Neurol. 364 (1996) 121-150
36. Olson L., Seiger Å., Ebendal T., and Hoffer B. Comparisons of nerve fiber growth from three major catecholamine-producing cell systems: adrenal medulla, superior cervical ganglion, and locus coeruleus. In: Erkänkö O. (Ed). Histochemistry and Cell Biology of Autonomous Neurons, SIF Cells, and Paraneurons (1980), Raven Press, New York 27-34
37. Palmer M., and Granholm A.-C. Electrophysiological effects of ethanol on hippocampal and cerebellar neurons cografted with locus coeruleus in oculo: role of the noradrenergic circuitry. J. Pharmacol. Exp. Ther. 260 (1992) 887-895
38. Rogers J.H. Immunohistochemical markers in rat brain: colocalisation of calretinin and calbindin-D28k with tyrosine hydroxylase. Brain Res. 587 (1992) 203-210
39. Srinivasan J., and Schmidt W. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-cloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease. Behav. Brain Res. 151 (2004) 191-199
40. Srivastava N., Granholm A.-C., and Gerhardt G.A. Collateral sprouting of central noradrenergic neurons during aging: histochemical and neurochemical studies in intraocular triple transplants. Exp. Neurol. 145 (1997) 524-535
41. Strömberg I., Björklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., and Humpel C. Glial cell line-derived neurotrophic factor (GDNF) is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124 (1993) 401-412
42. Strömberg I., Gemma C., Vila M., and Bickford P.C. Blueberry- and spirulina-enriched diets enhance striatal dopamine regeneration and induce a rapid, transient microglia activation after injury of the nigrostriatal dopamine system. Exp. Neurol. 196 (2005) 298-307
43. Strömberg I., and Johansson M. Re-initiated growth from mature ventral mesencephalon: an in oculo transplant study of nigrostriatal co-grafts. Exp. Brain Res. 101 (1994) 73-85
44. Traver S., Salthun-Lassalle B., Marien M., Hirsch E., Colpaert F., and Michel P. The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress. Mol. Pharmacol. 67 (2005) 1882-1891
45. Troadec J.-D., Marien M., Darios F., Hartmann A., Ruberg M., Colpaert F.C., and Michel P.P. Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress. J. Neurochem. 79 (2001) 200-210
46. Wallén Å., Zetterström R.H., Solomin L., Arvidsson M., Olson L., and Perlmann T. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in Nurr1 mutant mice. Exp. Cell Res. 253 (1999) 737-746
47. Willis L., Quintero E., Nelson M., and Granholm A. Regulation of trophic factor expression by innervating target regions in intraocular double transplants. Cell Transplant. 14 (2005) 21-29
48. Zarow C., Lyness S.A., Mortimer J.A., and Chui H.C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch. Neurol. 60 (2003) 337-341
49. Zawada W.M., Kirschman D.L., Cohen J.J., Heidenreich K.A., and Freed C.R. Growth factors rescue embryonic dopamine neurons from programmed cell death. Exp. Neurol. 146 (1996) 60-67
50. Zetterström R., Solomin L., Jansson L., Hoffer B., Olson L., and Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276 (1997) 248-250